FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Sylvia Perez

Research Profile

Disorders

Chemicals & Drugs

Living Beings

Anatomy

Co-author Network

Publications

TOP 3
Cassia R Overk; Sylvia E Perez; K K Soma; M D Taves; C Ma; Elliott J Mufson
Sex steroid levels and AD-like pathology in 3xTgAD mice.
Elliott J Mufson; Muhammad Nadeem; Sylvia E Perez; Scott E Counts; Jason Fritz; Stephen D. Ginsberg; Bin He; James Lah; Sue Leurgans; Joanne Wuu; Stephen W Scheff
Hippocampal proNGF signaling pathways and β-amyloid levels in mild cognitive impairment and Alzheimer disease.
Sylvia E Perez; Helene Peillon; Scott E Counts; Severine Coutadeur; Laurent Desire; Damianka P Getova; Changiz Geula; Stephen D. Ginsberg; Bin He; Elliott J Mufson
Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Sylvia Perez (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Cassia R Overk; Sylvia E Perez; K K Soma; M D Taves; C Ma; Elliott J Mufson
Sex steroid levels and AD-like pathology in 3xTgAD mice.
Journal of neuroendocrinology 2013;25(2):131-44.
2012: Elliott J Mufson; Muhammad Nadeem; Sylvia E Perez; Scott E Counts; Jason Fritz; Stephen D. Ginsberg; Bin He; James Lah; Sue Leurgans; Joanne Wuu; Stephen W Scheff
Hippocampal proNGF signaling pathways and β-amyloid levels in mild cognitive impairment and Alzheimer disease.
Journal of neuropathology and experimental neurology 2012;71(11):1018-29.
2012: Sylvia E Perez; Helene Peillon; Scott E Counts; Severine Coutadeur; Laurent Desire; Damianka P Getova; Changiz Geula; Stephen D. Ginsberg; Bin He; Elliott J Mufson
Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease.
The American journal of pathology 2012;180(2):526-40.
2012: Sylvia E Perez; Katherine R Sadleir; Robert Vassar; Muhammad Nadeem; Scott E Counts; Christy M Kelley; Joanna Matras; Elliott J Mufson
Dimebon alters hippocampal amyloid pathology in 3xTg-AD mice.
International journal of physiology, pathophysiology and pharmacology 2012;4(3):115-27.
2011: Sylvia E Perez; Bin He; Nadeem Muhammad; Kwang-Jin Oh; Margaret Fahnestock; Milos D Ikonomovic; Elliott J Mufson
Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice.
Neurobiology of disease 2011;41(2):338-52.
2011: Christy M Kelley; Cassia R Overk; Sylvia E Perez; David Wynick; Elliott J Mufson
Effect of neocortical and hippocampal amyloid deposition upon galaninergic and cholinergic neurites in AβPPswe/PS1ΔE9 mice.
Journal of Alzheimer's disease : JAD 2011;25(3):491-504.
2010: Sylvia E Perez; Brian M Berg; Kenneth A Moore; Bin He; Scott E Counts; Jason J Fritz; Yuan-Shih Hu; Orly Lazarov; James J Lah; Elliott J Mufson
DHA diet reduces AD pathology in young APPswe/PS1 Delta E9 transgenic mice: possible gender effects.
Journal of neuroscience research 2010;88(5):1026-40.
2010: Scott E Counts; Sylvia E Perez; Stephen D. Ginsberg; Elliott J Mufson
Neuroprotective role for galanin in Alzheimer's disease.
EXS 2010;102():143-62.
2010: Kwang-Jin Oh; Sylvia E Perez; Sarita Lagalwar; Laurel Vana; Lester Binder; Elliott J Mufson
Staging of Alzheimer's pathology in triple transgenic mice: a light and electron microscopic analysis.
International journal of Alzheimer's disease 2010;2010():.
2009: Sylvia E Perez; Stephen Lumayag; Beatrix Kovacs; Elliott J Mufson; Shunbin Xu
Beta-amyloid deposition and functional impairment in the retina of the APPswe/PS1DeltaE9 transgenic mouse model of Alzheimer's disease.
Investigative ophthalmology & visual science 2009;50(2):793-800.
2008: Elliott J Mufson; Scott E Counts; Sylvia E Perez; Stephen D. Ginsberg
Cholinergic system during the progression of Alzheimer's disease: therapeutic implications.
Expert review of neurotherapeutics 2008;8(11):1703-18.
2008: Scott E Counts; Sylvia E Perez; Elliott J Mufson
Galanin in Alzheimer's disease: neuroinhibitory or neuroprotective?
Cellular and molecular life sciences : CMLS 2008;65(12):1842-53.
2007: Sylvia E Perez; Saleem Dar; Milos D Ikonomovic; Steven T DeKosky; Elliott J Mufson
Cholinergic forebrain degeneration in the APPswe/PS1DeltaE9 transgenic mouse.
Neurobiology of disease 2007;28(1):3-15.
2005: Sylvia E Perez; Orly Lazarov; James B Koprich; Er-Yun Chen; Virginia Rodriguez-Menendez; Jack William Lipton; Sangram S Sisodia; Elliott J Mufson
Nigrostriatal dysfunction in familial Alzheimer's disease-linked APPswe/PS1DeltaE9 transgenic mice.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2005;25(44):10220-9.
2005: Elliott J Mufson; Scott E Counts; Sylvia E Perez; L Binder
Galanin plasticity in the cholinergic basal forebrain in Alzheimer's disease and transgenic mice.
Neuropeptides 2005;39(3):233-7.
2005: B He; Scott E Counts; Sylvia E Perez; J G Hohmann; James B Koprich; Jack William Lipton; Robert A Steiner; Jacqueline N Crawley; Elliott J Mufson
Ectopic galanin expression and normal galanin receptor 2 and galanin receptor 3 mRNA levels in the forebrain of galanin transgenic mice.
Neuroscience 2005;133(2):371-80.
2003: Scott E Counts; Sylvia E Perez; Stephen D. Ginsberg; Sonsoles de Lacalle; Elliott J Mufson
Galanin in Alzheimer disease.
Molecular interventions 2003;3(3):137-56.
2001: Scott E Counts; Sylvia E Perez; U Kahl; T Bartfai; R P Bowser; Darlene C Deecher; Deborah C Mash; Jacqueline N Crawley; Elliott J Mufson
Galanin: neurobiologic mechanisms and therapeutic potential for Alzheimer's disease.
CNS drug reviews 2001;7(4):445-70.